Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Ecology and Evolution|November 1, 2014
Reol: R interface to the Encyclopedia of LifeBarbara L Banbury, Brian C O'Meara
BMC Evolutionary Biology|October 24, 2009
Does evolutionary innovation in pharyngeal jaws lead to rapid lineage diversification in labrid fishes?Michael E Alfaro, Chad D Brock, Barbara L Banbury, et al.
BMC Evolutionary Biology|March 23, 2016
Phylogenomics of a rapid radiation: is chromosomal evolution linked to increased diversification in north american spiny lizards (Genus Sceloporus)?Adam D Leaché, Barbara L Banbury, Charles W Linkem, et al.
Systematic Biology|August 1, 2015
Short Tree, Long Tree, Right Tree, Wrong Tree: New Acquisition Bias Corrections for Inferring SNP PhylogeniesAdam D Leaché, Barbara L Banbury, Joseph Felsenstein, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
Pre-transplant TCR Network Topology Predicts Kidney Allograft Rejection Independent of HLA MismatchNicholas Borcherding, Jes M Sanders, Greg R Martens, et al.
Frontiers in Immunology|February 21, 2025
Pre-transplant T-cell clonal analysis identifies CD8<sup>+</sup> donor reactive clones that contribute to kidney transplant rejectionJes M Sanders, Barbara L Banbury, Erika L Schumacher, et al.
Cancer Medicine|March 28, 2018
Association of family history and survival in patients with colorectal cancer: a pooled analysis of eight epidemiologic studiesDawn Q Chong, Barbara L Banbury, Amanda I Phipps, et al.
Ebiomedicine|June 15, 2025
Vaccine-induced T cell responses correlate with reduced risk of severe COVID-19 in a placebo-controlled efficacy trialNina Hertoghs, Sanne Roels, Matthias Brückner, et al.
Annals of Clinical and Translational Neurology|May 7, 2024
Longitudinal study of immunity to SARS-CoV2 in ocrelizumab-treated MS patients up to 2 years after COVID-19 vaccinationIlya Kister, Ryan Curtin, Amanda L Piquet, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 18, 2020
Genetic Predictors of Severe Skin Toxicity in Patients with Stage III Colon Cancer Treated with Cetuximab: NCCTG N0147 (Alliance)Julia D Labadie, Xinwei Hua, Tabitha A Harrison, et al.
Pageof 3